159 related articles for article (PubMed ID: 33835337)
1. Large-volume cell-free and concentrated ascites reinfusion therapy improves venous flow in patients with liver cirrhosis.
Matsumoto N; Ogawa M; Kanda T; Matsuoka S; Moriyama M; Matsusaki K
J Med Ultrason (2001); 2021 Jul; 48(3):315-322. PubMed ID: 33835337
[TBL] [Abstract][Full Text] [Related]
2. Renal vein measurement using ultrasonography in patients with cirrhotic ascites and congestive heart failure.
Kaneko M; Matsumoto N; Kumagawa M; Watanabe Y; Hirayama M; Nakagawara H; Yamamoto T; Ogawa M; Moriyama M
J Med Ultrason (2001); 2021 Apr; 48(2):225-234. PubMed ID: 33768355
[TBL] [Abstract][Full Text] [Related]
3. Portal hemodynamics after large-volume paracentesis in patients with liver cirrhosis and tense ascites.
Sagarad SV; Chawla YK; Dhiman RK
Dig Dis Sci; 1998 Nov; 43(11):2470-2. PubMed ID: 9824136
[TBL] [Abstract][Full Text] [Related]
4. Cell-free and Concentrated Ascites Reinfusion Therapy for Refractory Ascites in Cirrhosis in Post-marketing Surveillance and the Role of Tolvaptan.
Iwasa M; Ishihara T; Kato M; Isoai A; Kobayashi R; Torii N; Soneda N; Takei Y
Intern Med; 2019 Nov; 58(21):3069-3075. PubMed ID: 31292400
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of cell-free and concentrated ascites reinfusion therapy against cirrhotic ascites in comparison with malignancy-related ascites.
Ito T; Hanafusa N; Soneda N; Isoai A; Kobayashi R; Torii N; Kato M
J Gastroenterol Hepatol; 2021 Nov; 36(11):3224-3232. PubMed ID: 34250635
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites.
Yokomichi N; Imai K; Sakamoto M; Horiki M; Yamauchi T; Miwa S; Inoue S; Uneno Y; Suzuki H; Wada T; Ichikawa Y; Morita T
BMC Cancer; 2022 Feb; 22(1):218. PubMed ID: 35227250
[TBL] [Abstract][Full Text] [Related]
7. Changes in Coagulation and Fibrinolytic Factors in Patients With Cirrhotic Refractory Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy: A Retrospective Observational Study in Japan.
Yorioka N; Namisaki T; Shibamoto A; Suzuki J; Kubo T; Iwai S; Tomooka F; Tanaka M; Takeda S; Fujimoto Y; Enomoto M; Muarata K; Inoue T; Tsuji Y; Fujinaga Y; Nishimura N; Kitagawa K; Takaya H; Kaji K; Kawaratani H; Akahane T; Mitoro A; Yamazaki M; Yoshiji H
In Vivo; 2023; 37(3):1226-1235. PubMed ID: 37103093
[TBL] [Abstract][Full Text] [Related]
8. Relationship among volume of paracentesis, portal blood flow and renal resistive index, evaluated by duplex Doppler ultrasonography in cirrhosis with tense ascites.
Caruso G; Catalano D; Carpinteri G; Di Fazzio S; Mazzone O
Recenti Prog Med; 1996 Apr; 87(4):164-6. PubMed ID: 8643878
[No Abstract] [Full Text] [Related]
9. Doppler hemodynamic study in portal hypertension and hepatic encephalopathy.
Perisic M; Ilic-Mostic T; Stojkovic M; Culafic D; Sarenac R
Hepatogastroenterology; 2005; 52(61):156-60. PubMed ID: 15783018
[TBL] [Abstract][Full Text] [Related]
10. Management of Refractory Ascites for Liver Transplant Candidates: A Novel Cell-free and Concentrated Ascites Reinfusion Therapy.
Shimizu S; Ohira M; Nakano R; Imaoka Y; Sato K; Tahara H; Ide K; Kobayashi T; Kuroda S; Ono H; Tanaka Y; Ohdan H
Transplant Proc; 2019 Oct; 51(8):2740-2744. PubMed ID: 31563243
[TBL] [Abstract][Full Text] [Related]
11. Cell-Free and Concentrated Ascites Reinfusion Therapy for Decompensated Liver Cirrhosis.
Kozaki K; IInuma M; Takagi T; Fukuda T; Sanpei T; Terunuma Y; Yatabe Y; Akano K
Ther Apher Dial; 2016 Aug; 20(4):376-82. PubMed ID: 27523078
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of reinfusion of concentrated ascitic fluid for malignant ascites: a concept-proof study.
Hanada R; Yokomichi N; Kato C; Miki K; Oyama S; Morita T; Kawahara R
Support Care Cancer; 2018 May; 26(5):1489-1497. PubMed ID: 29168037
[TBL] [Abstract][Full Text] [Related]
13. Verification of serum albumin elevating effect of cell-free and concentrated ascites reinfusion therapy for ascites patients: a retrospective controlled cohort study.
Yamada Y; Inui K; Hara Y; Fuji K; Sonoda K; Hashimoto K; Kamijo Y
Sci Rep; 2019 Jul; 9(1):10195. PubMed ID: 31308465
[TBL] [Abstract][Full Text] [Related]
14. Portal and splenic hemodynamics in cirrhotic patients: relationship between esophageal variceal bleeding and the severity of hepatic failure.
Kayacetin E; Efe D; Doğan C
J Gastroenterol; 2004 Jul; 39(7):661-7. PubMed ID: 15293137
[TBL] [Abstract][Full Text] [Related]
15. CART: Cell-free and Concentrated Ascites Reinfusion Therapy against malignancy-related ascites.
Ito T; Hanafusa N
Transfus Apher Sci; 2017 Oct; 56(5):703-707. PubMed ID: 28916401
[TBL] [Abstract][Full Text] [Related]
16. Ascites management by cell-free concentrated ascites reinfusion therapy during recovery from drug-induced acute liver injury: a case report.
Yasuda K; Asou M; Asakawa T; Araki M
J Med Case Rep; 2020 Oct; 14(1):192. PubMed ID: 33050943
[TBL] [Abstract][Full Text] [Related]
17. Endotoxin Activity Reflects an Increase in Body Temperature in Cirrhotic Patients With Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy.
Namisaki T; Tsuji Y; Kitade M; Yorioka N; Fujinaga Y; Sawada Y; Nishimura N; Kitagawa K; Inoue T; Takaya H; Kaji K; Kawaratani H; Moriya K; Akahane T; Mitoro A; Yoshiji H
In Vivo; 2022; 36(3):1477-1484. PubMed ID: 35478114
[TBL] [Abstract][Full Text] [Related]
18. Reduction of renal cortical blood flow assessed by Doppler in cirrhotic patients with refractory ascites.
Rivolta R; Maggi A; Cazzaniga M; Castagnone D; Panzeri A; Solenghi D; Lorenzano E; di Palo FQ; Salerno F
Hepatology; 1998 Nov; 28(5):1235-40. PubMed ID: 9794906
[TBL] [Abstract][Full Text] [Related]
19. Cell-free and concentrated ascites reinfusion therapy versus large-volume paracentesis for the treatment of cirrhotic patients with refractory ascites: A multicenter prospective observational study.
Hanai T; Kawaratani H; Nagano J; Suii H; Sakamaki A; Arase Y; Nakanishi H; Kogiso T; Okubo T; Miwa T; Shimizu S; Hige S; Atsukawa M; Shimizu M; Kurosaki M; Terai S; Kagawa T; Tokushige K; Yoshiji H
Hepatol Res; 2023 Mar; 53(3):238-246. PubMed ID: 36433862
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Doppler evaluation of the splenoportal venous system in various stages of cirrhosis: differences between right and left portal veins.
Kutlu R; Karaman I; Akbulut A; Baysal T; Sigirci A; Alkan A; Aladag M; Seckin Y; Saraç K
J Clin Ultrasound; 2002; 30(9):537-43. PubMed ID: 12404519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
